Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) for the prediction of (A) significant fibrosis (≥F2), (B) severe fibrosis (≥F3), and (C) cirrhosis (F4).
- Tomohiro Sekiguchi (760690)
- Takeji Umemura (272474)
- Naoyuki Fujimori (760691)
- Soichiro Shibata (496452)
- Yuki Ichikawa (760692)
- Takefumi Kimura (496453)
- Satoru Joshita (496451)
- Michiharu Komatsu (496454)
- Akihiro Matsumoto (496455)
- Eiji Tanaka (111967)
- Masao Ota (157102)
Publication date
June 2015
DOIAbstract
<p>Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) for the prediction of (A) significant fibrosis (≥F2), (B) severe fibrosis (≥F3), and (C) cirrhosis (F4).</p
Add to ORKG